retatrutide ada 2025 results Phase 3: 60% Achieved Surgical-Level Weight Loss ADA 2026: Retatrutide Revolution

As powerful anti-obesity drugs become more widely available, companies are repositioning themselves with new products and services.

GLP-1 is a hormone your body makes

Minimizes fat storage by directing glucose into muscle cells

Behind the trend is the surging popularity of GLP-1 weight loss medications, a class of so-called peptides approved to help users quickly shed pounds.

FDA-based guidance on what to do if you miss a GLP-1 dose

While the world has focused on the battle between injectables and oral tablets, the "Mucosal Frontier" addresses the three biggest hurdles in peptide therapy: 1 Bioavailability: By utilizing a mucosal delivery platform, the drug avoids first-pass metabolism in the liver, potentially offering a more efficient way for the body to utilize the peptide compared to traditional oral versions